Clinical Trial Update: Safety, PK and PD Study in Healthy Male Japanese Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety, pharmacokinetic (PK) and pharmacodynamic (PD) study in healthy male Japanese subjects has completed; Wyeth (now Pfizer) sponsored the trial rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED